balance equationreview2025-04-04
Difference 6000000 exceeds tolerance 1357600.000. Presentation or filing-vintage differences need review.
Revenue
$210.50M
Fiscal year ended 2026-07-03Operating income
$22.80M
Fiscal year ended 2026-07-03Free cash flow
$12.00M
Fiscal year ended 2026-07-03Varex Imaging Corp (VREX) reported revenue of $210.50M and net income of $15.70M for the fiscal year ended 2026-07-03. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Varex Imaging Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electronic Components, NEC.
Income
| Metric | 2026-07-03 | 2026-04-03 | 2026-01-02 | 2025-10-03 | 2025-07-04 | 2025-04-04 | 2025-01-03 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $210.50M | $216.00M | $209.60M | $228.90M | $203.00M | $212.90M | $199.80M | $205.70M | $209.10M | $206.20M |
| Cost of revenue | $133.80M | $143.40M | $139.80M | $151.10M | $135.50M | $136.20M | $131.30M | $138.60M | $142.20M | $140.40M |
| Gross profit | $76.70M | $72.60M | $69.80M | $77.80M | $67.50M | $76.70M | $68.50M | $67.10M | $66.90M | $65.80M |
| Operating income | $22.80M | $14.40M | $15.40M | $19.60M | -$80.70M | $22.10M | $11.20M | $10.90M | $9.30M | $7.70M |
| Net income | $15.70M | -$8.10M | $2.30M | $12.20M | -$89.10M | $6.90M | -$300.00K | -$51.10M | $1.40M | $1.40M |
| Research & development | $23.30M | $22.20M | $21.70M | $24.20M | $21.40M | $22.00M | $23.50M | $21.90M | $22.00M | $22.60M |
| Weighted-average diluted shares | shares 42.60M | shares 42.00M | shares 42.30M | Unavailable | shares 41.50M | shares 51.20M | shares 41.10M | Unavailable | shares 41.20M | shares 41.20M |
| Pretax income | $16.20M | -$6.40M | $3.80M | $14.10M | -$86.60M | $10.80M | $2.50M | $2.50M | $800.00K | $2.30M |
| Income tax expense | $300.00K | $1.60M | $1.40M | $1.90M | $2.50M | $3.70M | $2.60M | $53.50M | -$700.00K | $700.00K |
| Diluted EPS | $0.37 | $-0.19 | $0.05 | Unavailable | $-2.15 | $0.17 | $-0.01 | Unavailable | $0.03 | $0.03 |
| Selling, general & administrative | $30.60M | $36.00M | $32.70M | $34.00M | $32.90M | $32.60M | $33.80M | $34.30M | $35.60M | $35.50M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-07-03 | 2026-04-03 | 2026-01-02 | 2025-10-03 | 2025-07-04 | 2025-04-04 | 2025-01-03 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $99.20M | $85.30M | $119.50M | $145.00M | $136.40M | $205.10M | $176.00M | $168.70M | $156.40M | $141.80M |
| Total assets | $1.10B | $1.09B | $1.10B | $1.11B | $1.07B | $1.36B | $1.33B | $1.21B | $1.25B | $1.25B |
| Current assets | $633.10M | $625.60M | $633.60M | $641.80M | $619.50M | $683.80M | $656.90M | $649.90M | $649.30M | $651.90M |
| Total liabilities | $589.50M | $601.30M | $607.20M | $620.80M | $603.90M | $793.70M | $778.00M | $670.40M | $657.40M | $661.50M |
| Current liabilities | $187.40M | $195.30M | $163.00M | $187.20M | $176.70M | $168.80M | $150.50M | $195.90M | $194.60M | $154.10M |
| Total equity incl. NCI | $510.50M | $488.10M | $490.80M | $486.60M | $469.50M | $557.90M | $548.20M | $543.20M | $590.40M | $585.30M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $347.10M | $346.70M | $328.00M | $299.40M | $298.70M | $284.70M | $279.90M | $264.80M | $281.70M | $286.10M |
| Accounts receivable | $144.70M | $148.10M | $146.50M | $156.60M | $137.00M | $145.70M | $138.10M | $157.70M | $152.00M | $151.50M |
| Goodwill | $197.60M | $197.80M | $198.40M | $198.40M | $198.50M | $290.30M | $287.20M | $291.00M | $288.90M | $289.30M |
| Long-term debt | $328.90M | $329.00M | $366.20M | $366.00M | $366.00M | $565.80M | $565.60M | $397.10M | $396.90M | $441.40M |
| Accounts payable | $83.50M | $96.40M | $78.90M | $69.90M | $70.70M | $70.80M | $65.60M | $59.10M | $69.60M | $69.40M |
Cash flow
| Metric | 2026-07-03 | 2026-04-03 | 2026-01-02 | 2025-10-03 | 2025-07-04 | 2025-04-04 | 2025-01-03 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $21.00M | -$1.50M | -$16.10M | $7.90M | $7.70M | $16.60M | $9.50M | $25.90M | $8.00M | $3.10M |
| Capital expenditures | $9.00M | $6.20M | $10.70M | $5.60M | $6.30M | $6.80M | $4.20M | $6.00M | $4.70M | $5.80M |
| Investing cash flow | -$6.30M | -$3.10M | -$7.70M | -$700.00K | -$700.00K | $14.70M | -$3.00M | -$14.00M | $7.70M | -$1.30M |
| Financing cash flow | -$1.20M | -$29.30M | -$1.60M | $1.10M | -$201.20M | -$700.00K | $124.90M | $800.00K | -$1.10M | -$1.30M |
| Net change in cash | $13.40M | -$34.00M | -$25.40M | $8.60M | -$193.70M | $30.40M | $131.40M | $12.60M | $14.60M | $500.00K |
| Stock-based compensation | $3.80M | $4.00M | $3.80M | $3.40M | $3.70M | $3.80M | $4.10M | $3.50M | $3.90M | $4.20M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-07-03 | 2026-04-03 | 2026-01-02 | 2025-10-03 | 2025-07-04 | 2025-04-04 | 2025-01-03 | 2024-09-27 | 2024-06-28 | 2024-03-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $12.00M | -$7.70M | -$26.80M | $2.30M | $1.40M | $9.80M | $5.30M | $19.90M | $3.30M | -$2.70M |
| Gross margin | 36.4% | 33.6% | 33.3% | 34.0% | 33.3% | 36.0% | 34.3% | 32.6% | 32.0% | 31.9% |
| Operating margin | 10.8% | 6.7% | 7.3% | 8.6% | -39.8% | 10.4% | 5.6% | 5.3% | 4.4% | 3.7% |
| FCF margin | 5.7% | -3.6% | -12.8% | 1.0% | 0.7% | 4.6% | 2.7% | 9.7% | 1.6% | -1.3% |
| SBC / revenue | 1.8% | 1.9% | 1.8% | 1.5% | 1.8% | 1.8% | 2.1% | 1.7% | 1.9% | 2.0% |
| Current ratio | 3.38x | 3.20x | 3.89x | 3.43x | 3.51x | 4.05x | 4.36x | 3.32x | 3.34x | 4.23x |
| Revenue YoY growth | 3.7% | 1.5% | 4.9% | 11.3% | -2.9% | 3.2% | 5.2% | -9.5% | -9.9% | -9.6% |
| Net margin | 7.5% | -3.8% | 1.1% | 5.3% | -43.9% | 3.2% | -0.2% | -24.8% | 0.7% | 0.7% |
| R&D / revenue | 11.1% | 10.3% | 10.4% | 10.6% | 10.5% | 10.3% | 11.8% | 10.6% | 10.5% | 11.0% |
| CapEx / revenue | 4.3% | 2.9% | 5.1% | 2.4% | 3.1% | 3.2% | 2.1% | 2.9% | 2.2% | 2.8% |
| Long-term debt / equity | 0.64x | Unavailable | Unavailable | 0.75x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 1.9% | Unavailable | 36.8% | 13.5% | Unavailable | 34.3% | 104.0% | 2140.0% | -87.5% | 30.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open VREX in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-Q · Filed 2026-02-10View SEC filing
10-K · Filed 2025-11-18View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Reconciliation checks needing review
6 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2025-01-03
Difference 6000000 exceeds tolerance 1332200.000. Presentation or filing-vintage differences need review.
balance equationreview2024-06-28
Difference 4900000 exceeds tolerance 1252700.000. Presentation or filing-vintage differences need review.
balance equationreview2024-03-29
Difference 4900000 exceeds tolerance 1251700.000. Presentation or filing-vintage differences need review.
balance equationreview2023-09-29
Difference 4900000 exceeds tolerance 1249600.000. Presentation or filing-vintage differences need review.
balance equationreview2022-09-30
Difference 4100000 exceeds tolerance 1184400.000. Presentation or filing-vintage differences need review.